Paraneoplastic autoantibody evaluation, CSF
Paraneoplastic autoantibody evaluation, CSF-14306
Paraneoplastic autoantibody evaluation, CSF
14306
LAB14306
PAC1
Anti-Hu
Antineuronal
Cerebellar antibodies
Dorsal root ganglion antibody
Antineuronal
Cerebellar antibodies
Dorsal root ganglion antibody
- Paraneoplastic Interpretation, CSF
- Anti-Neuronal Nuclear Ab, Type 1
- Anti-Neuronal Nuclear Ab, Type 2
- Anti-Neuronal Nuclear Ab, Type 3
- Anti-Glial Nuclear Ab, Type 1
- Purkinje Cell Cytoplasmic Ab Type 1
- Purkinje Cell Cytoplasmic Ab Type 2
- Purkinje Cell Cytoplasmc Ab Type Tr
- Amphiphysin Ab, CSF
- CRMP-5-IgG, CSF
- An aid in the diagnosis of paraneoplastic neurological autoimmune disorders related to carcinoma of lung, breast, ovary, thymoma, or Hodgkin's lymphoma
- In patients with a history of tobacco use or other lung cancer risk, or if thymoma is suspected, Paraneoplastic autoantibody evaluation, serum is also recommended.
Cerebrospinal fluid (CSF)
4.0 mL
2.0 mL
Do not spin; submit entire specimen
Refrigerated (preferred) - 28 days
Ambient - 72 hours
Frozen - 28 days
Mayo Clinic Laboratories (PAC1): R-NX
Daily
3 - 4 days if Negative;5 - 8 days if Positive
Immunofluorescence Assay (IFA), Radioimmunoassay, Cell-Binding Assay (CBA) and Western Blot
Negative at < 1:2
86255 x 9
Additional CPT codes (if appropriate):
83519
84182 x 7
86255 x 9
86256 x 5
86341
Additional CPT codes (if appropriate):
83519
84182 x 7
86255 x 9
86256 x 5
86341
06/05/2013
05/19/2020